Celldex Therapeutics
CLDX
$20.82
Share price
3.79%
Change (1 day)
-39.93%
Change (1 year)
Categories
Earnings for Celldex Therapeutics (CLDX)
Earnings in 2025 (TTM): -$0.22 Billion USD
According to Celldex Therapeutics's latest financial reports the company's current earnings are $7.55 Million USD. In 2024 the company made an earning of -$0.2 Billion USD a decrease over its 2023 earnings that were of -$0.15 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Celldex Therapeutics from 1996 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -$0.22 Billion | 11.34% |
| 2024 | -$0.2 Billion | 37.34% |
| 2023 | -$0.15 Billion | 32.63% |
| 2022 | -$0.11 Billion | 54.88% |
| 2021 | -$69.15 Million | 39.49% |
| 2020 | -$49.58 Million | -9.08% |
| 2019 | -$54.53 Million | -28.64% |
| 2018 | -$76.41 Million | -30.11% |
| 2017 | -$0.11 Billion | -17.75% |
| 2016 | -$0.14 Billion | 4.5% |
| 2015 | -$0.13 Billion | 4.09% |
| 2014 | -$0.13 Billion | 51.57% |
| 2013 | -$80.63 Million | 40.1% |
| 2012 | -$57.55 Million | |
| 2010 | -$1.25 Million | -96.59% |
| 2009 | -$36.61 Million | |
| 2006 | -$22.37 Million | |
| 2004 | -$13.59 Million | 15.75% |
| 2003 | -$11.74 Million | -18.69% |
| 2002 | -$14.44 Million | -41.22% |
| 2001 | -$24.56 Million | 59% |
| 2000 | -$15.45 Million | 27.65% |
| 1999 | -$12.1 Million | 53.12% |
| 1998 | -$7.9 Million | 2.6% |
| 1997 | -$7.7 Million | -33.62% |
| 1996 | -$11.6 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | -$0.8 Billion | 263.97% | 🇺🇸 USA |
 Agenus
AGEN | -$94.24 Million | -56.62% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.9 Million | -99.59% | 🇺🇸 USA |
 Amgen AMGN | $6.65 B | -3,161.57% | 🇺🇸 USA |
 Pfizer PFE | $10.34 B | -4,860.85% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $5.41 B | -2,591.20% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | -$4.21 Million | -98.06% | 🇺🇸 USA |